Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""van den Bemt PMLA"" wg kryterium: Autor


Tytuł :
Initiation of oral anticoagulant therapy in orthopedic and surgical patients: an algorithm compared with routine dosing
Autorzy :
van den Bemt, PMLA
Beinema, M
van Roon, EN
Sijtsma, J
Baars, WA
Mencke, HJ
Brouwers, JRBJ
Pokaż więcej
Temat :
oral anticoagulant
acenocoumarol
initiation
routine dosing
algorithm
hospital
WARFARIN THERAPY
HOSPITALIZED-PATIENTS
DOSE REQUIREMENT
RANDOMIZED TRIAL
PREDICTION
DOSAGE
STABILIZATION
ASSOCIATION
SYSTEM
RISK
Źródło :
European Journal of Clinical Pharmacology, 58(3), 203 - 208. Springer Verlag
Tytuł :
Adverse drug events as cause of hospitalisation.
Autorzy :
Van den Bemt, PMLA
Pokaż więcej
Źródło :
Journal of Clinical Nursing (John Wiley & Sons, Inc.); Oct2010 Supplement, Vol. 19, p62-63, 2p
Czasopismo naukowe
Tytuł :
Sex differences associated with adverse drug reactions resulting in hospital admissions.
Autorzy :
Hendriksen LC; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Clinical Pharmacy, Tergooi Hospital, Hilversum, The Netherlands.
van der Linden PD; Department of Clinical Pharmacy, Tergooi Hospital, Hilversum, The Netherlands.
Lagro-Janssen ALM; Department of Primary and Community Care, Gender and Women's Health, Radboud University Medical Centre, Nijmegen, The Netherlands.
van den Bemt PMLA; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
Siiskonen SJ; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Doctoral Programme in Population Health, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Teichert M; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Kuiper JG; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
Herings RMC; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.; Department of Epidemiology and Data Science, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.
Stricker BH; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Visser LE; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands. .; Department of Clinical Pharmacy, Haga Teaching Hospital, The Hague, The Netherlands. .; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands. .
Pokaż więcej
Źródło :
Biology of sex differences [Biol Sex Differ] 2021 May 03; Vol. 12 (1), pp. 34. Date of Electronic Publication: 2021 May 03.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The added value of H 2 antagonists in premedication regimens during paclitaxel treatment.
Autorzy :
Cox JM; Department of Clinical Pharmacy and Maasstad Lab, Maasstad Hospital, Rotterdam, The Netherlands.
van Doorn L; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Malmberg R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Bosch TM; Department of Clinical Pharmacy and Maasstad Lab, Maasstad Hospital, Rotterdam, The Netherlands.
van den Bemt PMLA; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
Boere IA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
van Leeuwen RWF; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. .; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands. .
Pokaż więcej
Źródło :
British journal of cancer [Br J Cancer] 2021 May; Vol. 124 (10), pp. 1647-1652. Date of Electronic Publication: 2021 Mar 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The Effect of Medication Reconciliation via a Patient Portal on Medication Discrepancies: A Randomized Noninferiority Study.
Autorzy :
Ebbens MM; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands; Department of Hospital Pharmacy, St Jansdal Hospital, Harderwijk, the Netherlands; Department of Hospital Pharmacy, Erasmus MC, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: .
Gombert-Handoko KB; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands.
Wesselink EJ; Department of Clinical Pharmacy, Zaans Medical Centre, Zaandam, the Netherlands.
van den Bemt PMLA; Department of Hospital Pharmacy, Erasmus MC, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Pokaż więcej
Źródło :
Journal of the American Medical Directors Association [J Am Med Dir Assoc] 2021 Apr 24. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Medication-Related Hospital Readmissions Within 30 Days of Discharge: Prevalence, Preventability, Type of Medication Errors and Risk Factors.
Autorzy :
Uitvlugt EB; Onze Lieve Vrouwe Gasthuis OLVG, Department of Hospital Pharmacy, Amsterdam, Netherlands.
Janssen MJA; Onze Lieve Vrouwe Gasthuis OLVG, Department of Hospital Pharmacy, Amsterdam, Netherlands.
Siegert CEH; Onze Lieve Vrouwe Gasthuis OLVG, Department of Internal Medicine, Amsterdam, Netherlands.
Kneepkens EL; Onze Lieve Vrouwe Gasthuis OLVG, Department of Hospital Pharmacy, Amsterdam, Netherlands.
van den Bemt BJF; Department of Pharmacy, Sint Maartenskliniek, Nijmegen, Netherlands.; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, Netherlands.
van den Bemt PMLA; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands.
Karapinar-Çarkit F; Onze Lieve Vrouwe Gasthuis OLVG, Department of Hospital Pharmacy, Amsterdam, Netherlands.
Pokaż więcej
Źródło :
Frontiers in pharmacology [Front Pharmacol] 2021 Apr 13; Vol. 12, pp. 567424. Date of Electronic Publication: 2021 Apr 13 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies